BioCentury
ARTICLE | Company News

SmithKline vaccine license from MedImmune

July 19, 2000 7:00 AM UTC

SBH received from MEDI worldwide exclusive rights to develop and commercialize a Streptococcus pneumoniae vaccine technology in preclinical evaluation. MEDI may receive an up-front payment and milesto...